AngioDynamics, Inc. Operating Lease, Payments
AngioDynamics, Inc. (ANGO) reported Operating Lease, Payments of $1.81 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-07-14
- AngioDynamics, Inc. operating lease, payments for the quarter ending 2026-05-31 was $412.00K, a 21.82% decline year-over-year.
- AngioDynamics, Inc. operating lease, payments for the quarter ending 2026-02-28 was $412.00K, a 26.43% decline year-over-year.
- AngioDynamics, Inc. operating lease, payments for the quarter ending 2025-11-30 was $487.00K, a 12.72% decline year-over-year.
- AngioDynamics, Inc. operating lease, payments for the quarter ending 2025-08-31 was $497.00K, a 11.57% decline year-over-year.
- AngioDynamics, Inc. operating lease, payments for fiscal 2026 was $1.81M, a 18.08% decline from fiscal 2025.
- AngioDynamics, Inc. operating lease, payments for fiscal 2025 was $2.21M, a 3.03% increase from fiscal 2024.
- AngioDynamics, Inc. operating lease, payments for fiscal 2024 was $2.14M, a 21.88% decline from fiscal 2023.
- AngioDynamics, Inc. operating lease, payments for fiscal 2023 was $2.74M, a 0.70% increase from fiscal 2022.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-05-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $824.00K derived: sum of 2 quarters · filed 2026-07-14 | $1.31M derived: sum of 3 quarters · filed 2026-07-14 | $1.81M 10-K · filed 2026-07-14 |
| 2026-02-28 | $412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-02 | $899.00K derived: sum of 2 quarters · filed 2026-04-02 | $1.40M 10-Q · filed 2026-04-02 | $1.92M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-11-30 | $487.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-06 | $984.00K 10-Q · filed 2026-01-06 | $1.51M derived: sum of 3 quarters · filed 2026-07-14 | $2.07M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-08-31 | $497.00K 10-Q · filed 2025-10-02 | $1.02M derived: sum of 2 quarters · filed 2026-07-14 | $1.58M derived: sum of 3 quarters · filed 2026-07-14 | $2.14M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-05-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.09M derived: sum of 2 quarters · filed 2026-07-14 | $1.65M derived: sum of 3 quarters · filed 2026-07-14 | $2.21M 10-K · filed 2026-07-14 |
| 2025-02-28 | $560.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-02 | $1.12M derived: sum of 2 quarters · filed 2026-04-02 | $1.68M 10-Q · filed 2026-04-02 | $2.27M derived: sum of 4 quarters · filed 2026-04-02 |
| 2024-11-30 | $558.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-06 | $1.12M 10-Q · filed 2026-01-06 | $1.71M derived: sum of 3 quarters · filed 2026-01-06 | $2.20M derived: sum of 4 quarters · filed 2026-01-06 |
| 2024-08-31 | $562.00K 10-Q · filed 2025-10-02 | $1.15M derived: sum of 2 quarters · filed 2025-10-02 | $1.64M derived: sum of 3 quarters · filed 2025-10-02 | $2.17M derived: sum of 4 quarters · filed 2025-10-02 |
| 2024-05-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $1.08M derived: sum of 2 quarters · filed 2025-07-18 | $1.61M derived: sum of 3 quarters · filed 2025-07-18 | $2.14M 10-K · filed 2025-07-18 |
| 2024-02-29 | $491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-02 | $1.02M derived: sum of 2 quarters · filed 2025-04-02 | $1.55M 10-Q · filed 2025-04-02 | $2.22M derived: sum of 4 quarters · filed 2025-04-02 |
| 2023-11-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-08 | $1.06M 10-Q · filed 2025-01-08 | $1.73M derived: sum of 3 quarters · filed 2025-01-08 | $2.42M derived: sum of 4 quarters · filed 2025-01-08 |
| 2023-08-31 | $532.00K 10-Q · filed 2024-10-03 | $1.20M derived: sum of 2 quarters · filed 2024-10-03 | $1.89M derived: sum of 3 quarters · filed 2024-10-03 | $2.58M derived: sum of 4 quarters · filed 2024-10-03 |
| 2023-05-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | $1.36M derived: sum of 2 quarters · filed 2024-07-25 | $2.05M derived: sum of 3 quarters · filed 2024-07-25 | $2.74M 10-K · filed 2024-07-25 |
| 2023-02-28 | $695.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $1.39M derived: sum of 2 quarters · filed 2024-04-09 | $2.08M 10-Q · filed 2024-04-09 | $2.76M derived: sum of 4 quarters · filed 2024-04-09 |
| 2022-11-30 | $693.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-08 | $1.38M 10-Q · filed 2024-01-08 | $2.07M derived: sum of 3 quarters · filed 2024-01-08 | $2.75M derived: sum of 4 quarters · filed 2024-01-08 |
| 2022-08-31 | $691.00K 10-Q · filed 2023-10-05 | $1.37M derived: sum of 2 quarters · filed 2023-10-05 | $2.06M derived: sum of 3 quarters · filed 2023-10-05 | $2.73M derived: sum of 4 quarters · filed 2023-10-05 |
| 2022-05-31 | $682.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03 | $1.36M derived: sum of 2 quarters · filed 2023-08-03 | $2.04M derived: sum of 3 quarters · filed 2023-08-03 | $2.72M 10-K · filed 2023-08-03 |
| 2022-02-28 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-31 | $1.36M derived: sum of 2 quarters · filed 2023-03-31 | $2.04M 10-Q · filed 2023-03-31 | $2.72M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-11-30 | $677.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-06 | $1.36M 10-Q · filed 2023-01-06 | $2.04M derived: sum of 3 quarters · filed 2023-01-06 | $2.70M derived: sum of 4 quarters · filed 2023-01-06 |
| 2021-08-31 | $682.00K 10-Q · filed 2022-10-11 | $1.36M derived: sum of 2 quarters · filed 2022-10-11 | $2.02M derived: sum of 3 quarters · filed 2022-10-11 | $2.71M derived: sum of 4 quarters · filed 2022-10-11 |
| 2021-05-31 | $678.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $1.34M derived: sum of 2 quarters · filed 2022-07-22 | $2.03M derived: sum of 3 quarters · filed 2022-07-22 | $2.70M 10-K · filed 2022-07-22 |
| 2021-02-28 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-07 | $1.35M derived: sum of 2 quarters · filed 2022-04-07 | $2.02M 10-Q · filed 2022-04-07 | $2.63M derived: sum of 4 quarters · filed 2022-04-07 |
| 2020-11-30 | $688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-07 | $1.36M 10-Q · filed 2022-01-07 | $1.97M derived: sum of 3 quarters · filed 2022-01-07 | $3.17M derived: sum of 4 quarters · filed 2022-01-07 |
| 2020-08-31 | $672.00K 10-Q · filed 2021-09-30 | $1.28M derived: sum of 2 quarters · filed 2021-09-30 | $2.48M derived: sum of 3 quarters · filed 2021-09-30 | $2.48M derived: sum of 4 quarters · filed 2021-09-30 |
| 2020-05-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $1.81M derived: sum of 2 quarters · filed 2021-07-27 | $1.81M derived: sum of 3 quarters · filed 2021-07-27 | $2.37M 10-K · filed 2021-07-27 |
| 2020-02-29 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $1.20M derived: sum of 2 quarters · filed 2021-03-31 | $1.77M 10-Q · filed 2021-03-31 | |
| 2019-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-08 | $563.00K 10-Q · filed 2021-01-08 | ||
| 2019-08-31 | $563.00K 10-Q · filed 2020-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |